BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3198642)

  • 1. The activator protein for glucosylceramide beta-glucosidase from guinea pig liver. Improved isolation method and complete amino acid sequence.
    Sano A; Radin NS; Johnson LL; Tarr GE
    J Biol Chem; 1988 Dec; 263(36):19597-601. PubMed ID: 3198642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The carbohydrate moiety of the activator protein for glucosylceramide beta-glucosidase.
    Sano A; Radin NS
    Biochem Biophys Res Commun; 1988 Aug; 154(3):1197-203. PubMed ID: 3408492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The binding of glucosylceramidase to glucosylceramide is promoted by its activator protein.
    Vaccaro AM; Muscillo M; Salvioli R; Tatti M; Gallozzi E; Suzuki K
    FEBS Lett; 1987 Jun; 216(2):190-4. PubMed ID: 3582671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The precursor of sulfatide activator protein is processed to three different proteins.
    Fürst W; Machleidt W; Sandhoff K
    Biol Chem Hoppe Seyler; 1988 May; 369(5):317-28. PubMed ID: 3048308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of saposins A and C on the enzymatic hydrolysis of liposomal glucosylceramide.
    Vaccaro AM; Tatti M; Ciaffoni F; Salvioli R; Barca A; Scerch C
    J Biol Chem; 1997 Jul; 272(27):16862-7. PubMed ID: 9201993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation of the cerebroside sulfate activator (CSAct or saposin B) from human urine.
    Fluharty AL; Lombardo C; Louis A; Stevens RL; Whitelegge J; Waring AJ; To T; Fluharty CB; Faull KF
    Mol Genet Metab; 1999 Nov; 68(3):391-403. PubMed ID: 10562467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional human saposins expressed in Escherichia coli. Evidence for binding and activation properties of saposins C with acid beta-glucosidase.
    Qi X; Leonova T; Grabowski GA
    J Biol Chem; 1994 Jun; 269(24):16746-53. PubMed ID: 8206997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Saposin A: second cerebrosidase activator protein.
    Morimoto S; Martin BM; Yamamoto Y; Kretz KA; O'Brien JS; Kishimoto Y
    Proc Natl Acad Sci U S A; 1989 May; 86(9):3389-93. PubMed ID: 2717620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and characterization of prosaposin from human milk.
    Kondoh K; Hineno T; Sano A; Kakimoto Y
    Biochem Biophys Res Commun; 1991 Nov; 181(1):286-92. PubMed ID: 1958198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of saposins, acidic lipids, and glucosylceramidase.
    Morimoto S; Kishimoto Y; Tomich J; Weiler S; Ohashi T; Barranger JA; Kretz KA; O'Brien JS
    J Biol Chem; 1990 Feb; 265(4):1933-7. PubMed ID: 2298731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cerebroside sulfate activator from pig kidney: purification and molecular structure.
    Fluharty AL; Katona Z; Meek WE; Frei K; Fowler AV
    Biochem Med Metab Biol; 1992 Feb; 47(1):66-85. PubMed ID: 1562358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and characterization of a bioactive 82-residue sphingolipid activator protein, saposin C.
    Weiler S; Carson W; Lee Y; Teplow DB; Kishimoto Y; O'Brien JS; Barranger JA; Tomich JM
    J Mol Neurosci; 1993; 4(3):161-72. PubMed ID: 8292489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further studies on the activation of glucocerebrosidase by a heat-stable factor from Gaucher spleen.
    Prence E; Chakravorti S; Basu A; Clark LS; Glew RH; Chambers JA
    Arch Biochem Biophys; 1985 Jan; 236(1):98-109. PubMed ID: 3966805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure of full-length cDNA coding for sulfatide activator, a Co-beta-glucosidase and two other homologous proteins: two alternate forms of the sulfatide activator.
    Nakano T; Sandhoff K; Stümper J; Christomanou H; Suzuki K
    J Biochem; 1989 Feb; 105(2):152-4. PubMed ID: 2498298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Saposin D: a sphingomyelinase activator.
    Morimoto S; Martin BM; Kishimoto Y; O'Brien JS
    Biochem Biophys Res Commun; 1988 Oct; 156(1):403-10. PubMed ID: 2845979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleotide sequence of cloned cDNA for human sphingolipid activator protein 1 precursor.
    Dewji NN; Wenger DA; O'Brien JS
    Proc Natl Acad Sci U S A; 1987 Dec; 84(23):8652-6. PubMed ID: 2825202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary structure of the cytosolic beta-glucosidase of guinea pig liver.
    Hays WS; Jenison SA; Yamada T; Pastuszyn A; Glew RH
    Biochem J; 1996 Nov; 319 ( Pt 3)(Pt 3):829-37. PubMed ID: 8920987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An endogenous activator protein in human placenta for enzymatic degradation of glucosylceramide.
    Vaccaro AM; Muscillo M; Gallozzi E; Salvioli R; Tatti M; Suzuki K
    Biochim Biophys Acta; 1985 Sep; 836(2):157-66. PubMed ID: 4027262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-terminal amino-acid sequence of a sphingolipid activator protein missing in a new human Gaucher disease variant.
    Christomanou H; Kleinschmidt T; Braunitzer G
    Biol Chem Hoppe Seyler; 1987 Sep; 368(9):1193-6. PubMed ID: 3675870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complete amino-acid sequence of the naturally occurring A2 activator protein for enzymic sphingomyelin degradation: identity to the sulfatide activator protein (SAP-1).
    Kleinschmidt T; Christomanou H; Braunitzer G
    Biol Chem Hoppe Seyler; 1988 Dec; 369(12):1361-5. PubMed ID: 3242555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.